- Home
- Publications
- Publication Search
- Publication Details
Title
Designer Oncolytic Adenovirus: Coming of Age
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 6, Pages 201
Publisher
MDPI AG
Online
2018-06-14
DOI
10.3390/cancers10060201
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncorine, the World First Oncolytic Virus Medicine and its Update in China
- (2018) Min Liang CURRENT CANCER DRUG TARGETS
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells
- (2018) Y. K. Stella Man et al. MOLECULAR CANCER THERAPEUTICS
- Oncolytic Virus Combination Therapy: Killing One Bird with Two Stones
- (2018) Nikolas Tim Martin et al. MOLECULAR THERAPY
- Potentiating prostate cancer immunotherapy with oncolytic viruses
- (2018) Patrick Lee et al. Nature Reviews Urology
- Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production
- (2018) Hiroyasu Konno et al. ONCOGENE
- Polysialic acid is a cellular receptor for human adenovirus 52
- (2018) Annasara Lenman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy
- (2018) Marie-Claude Bourgeois-Daigneault et al. Science Translational Medicine
- Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
- (2018) Adel Samson et al. Science Translational Medicine
- Adenoviral vector with shield and adapter increases tumor specificity and escapes liver and immune control
- (2018) Markus Schmid et al. Nature Communications
- Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor
- (2018) Nicole Stichling et al. PLoS Pathogens
- Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy
- (2018) Carmen Aguirre-Hernández et al. Oncogenesis
- EMT and MET: necessary or permissive for metastasis?
- (2017) Mohit Kumar Jolly et al. Molecular Oncology
- Upholding a role for EMT in breast cancer metastasis
- (2017) Xin Ye et al. NATURE
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Affibody Molecules in Biotechnological and Medical Applications
- (2017) Stefan Ståhl et al. TRENDS IN BIOTECHNOLOGY
- Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages
- (2017) Mareike D. Maler et al. mBio
- Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
- (2017) Pengju Wang et al. Nature Communications
- Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus
- (2017) Abhay Kotecha et al. Nature Communications
- Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange
- (2017) Sandrine Guillard et al. Nature Communications
- T-cell receptor-engineered T cells for cancer treatment: current status and future directions
- (2017) Yu Ping et al. Protein & Cell
- Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer Cells
- (2017) Dhaval S. Sanchala et al. Frontiers in Pharmacology
- Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
- (2017) Zong Sheng Guo et al. Frontiers in Immunology
- Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
- (2017) Sam Illingworth et al. Molecular Therapy-Oncolytics
- Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
- (2017) Arthur Dyer et al. Molecular Therapy-Oncolytics
- OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution
- (2017) Irene Kuhn et al. Molecular Therapy-Oncolytics
- Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
- (2017) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 – Support for clinical studies on advanced cancer treatment
- (2017) Lukasz Kuryk et al. PLoS One
- The relevance of coagulation factor X protection of adenoviruses in human sera
- (2016) M R Duffy et al. GENE THERAPY
- Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
- (2016) E Eriksson et al. GENE THERAPY
- Oncolytic viruses—immunotherapeutics on the rise
- (2016) Brian A. Keller et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The coming of age of de novo protein design
- (2016) Po-Ssu Huang et al. NATURE
- Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies
- (2016) Hanni Uusi-Kerttula et al. Oncotarget
- Native and engineered tropism of vectors derived from a rare species D adenovirus serotype 43
- (2016) Natalya Belousova et al. Oncotarget
- The E1B19K-deleted oncolytic adenovirus mutant AdΔ19K sensitizes pancreatic cancer cells to drug-induced DNA-damage by down-regulating Claspin and Mre11
- (2016) Constantia Pantelidou et al. Oncotarget
- Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity
- (2016) Evelyne Beerling et al. Cell Reports
- Recent advances in oncolytic adenovirus therapies for cancer
- (2016) Amanda Rosewell Shaw et al. Current Opinion in Virology
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Viruses: Therapeutics With an Identity Crisis
- (2016) Caroline J. Breitbach et al. EBioMedicine
- Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy
- (2015) Andreas Plückthun Annual Review of Pharmacology and Toxicology
- Talimogene Laherparepvec: First Global Approval
- (2015) Sarah L. Greig DRUGS
- Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies
- (2015) Hanni Uusi-Kerttula et al. HUMAN GENE THERAPY
- Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Resultsin vitro, in rodents and in humans
- (2015) Simona Bramante et al. INTERNATIONAL JOURNAL OF CANCER
- Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
- (2015) Norman Woller et al. MOLECULAR THERAPY
- Polysialylation controls dendritic cell trafficking by regulating chemokine recognition
- (2015) E. Kiermaier et al. SCIENCE
- Interaction of Human Tumor Viruses with Host Cell Surface Receptors and Cell Entry
- (2015) Georgia Schäfer et al. Viruses-Basel
- Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
- (2015) Hanni Uusi-Kerttula et al. Viruses-Basel
- A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors
- (2015) Julius W. Kim et al. Scientific Reports
- Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints
- (2015) Hong Jiang et al. Current Opinion in Virology
- Human Adenovirus 52 Uses Sialic Acid-containing Glycoproteins and the Coxsackie and Adenovirus Receptor for Binding to Target Cells
- (2015) Annasara Lenman et al. PLoS Pathogens
- Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo
- (2015) Jiangtao Ma et al. PLoS Pathogens
- Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
- (2015) Cristian Capasso et al. OncoImmunology
- Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin
- (2015) Maximilian Richter et al. Molecular Therapy-Methods & Clinical Development
- Association of oncolytic adenoviruses with chemotherapies: An overview and future directions
- (2014) Christian Bressy et al. BIOCHEMICAL PHARMACOLOGY
- Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
- (2014) A. Rodriguez-Garcia et al. CLINICAL CANCER RESEARCH
- Polysialic acid: Biosynthesis, novel functions and applications
- (2014) Karen J. Colley et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood
- (2014) Y Di et al. GENE THERAPY
- Retargeting Adenovirus Serotype 48 Fiber Knob Domain by Peptide Incorporation
- (2014) Lynda Coughlan et al. HUMAN GENE THERAPY
- ORCA-010, a Novel Potency-Enhanced Oncolytic Adenovirus, Exerts Strong Antitumor Activity in Preclinical Models
- (2014) Wenliang Dong et al. HUMAN GENE THERAPY
- Recombinant Ad35 adenoviral proteins as potent modulators of human T-cell activation
- (2014) Joanne Hay et al. IMMUNOLOGY
- Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
- (2014) Svend O. Freytag et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002)
- (2014) Lindsey R. Baden et al. JOURNAL OF INFECTIOUS DISEASES
- The sweet spot: defining virus–sialic acid interactions
- (2014) Jennifer E. Stencel-Baerenwald et al. NATURE REVIEWS MICROBIOLOGY
- Sialic Acids in the Brain: Gangliosides and Polysialic Acid in Nervous System Development, Stability, Disease, and Regeneration
- (2014) Ronald L. Schnaar et al. PHYSIOLOGICAL REVIEWS
- Multifunctional CD40L: pro- and anti-neoplastic activity
- (2014) Aleksandra Korniluk et al. TUMOR BIOLOGY
- IL-1α and Complement Cooperate in Triggering Local Neutrophilic Inflammation in Response to Adenovirus and Eliminating Virus-Containing Cells
- (2014) Nelson C. Di Paolo et al. PLoS Pathogens
- Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of v 6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
- (2013) M. D. Allen et al. CLINICAL CANCER RESEARCH
- Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer
- (2013) S O Freytag et al. GENE THERAPY
- A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
- (2013) Kenneth H. Kim et al. GYNECOLOGIC ONCOLOGY
- Evolution of oncolytic viruses: novel strategies for cancer treatment
- (2013) Matthew J Atherton et al. Immunotherapy
- CD46: The ‘multitasker’ of complement proteins
- (2013) Hidekazu Yamamoto et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Structural and Functional Studies on the Interaction of Adenovirus Fiber Knobs and Desmoglein 2
- (2013) H. Wang et al. JOURNAL OF VIROLOGY
- Adenovirus Detection by the cGAS/STING/TBK1 DNA Sensing Cascade
- (2013) E. Lam et al. JOURNAL OF VIROLOGY
- Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement
- (2013) Zhili Xu et al. NATURE MEDICINE
- Development of a generic adenovirus delivery system based on structure-guided design of bispecific trimeric DARPin adapters
- (2013) B. Dreier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular evolution of human adenoviruses
- (2013) Christopher M. Robinson et al. Scientific Reports
- Penton-Dodecahedral Particles Trigger Opening of Intercellular Junctions and Facilitate Viral Spread during Adenovirus Serotype 3 Infection of Epithelial Cells
- (2013) Zhuo-Zhuang Lu et al. PLoS Pathogens
- The Structural Basis of Antibody-Antigen Recognition
- (2013) Inbal Sela-Culang et al. Frontiers in Immunology
- MAGE-A antigens as targets in tumour therapy
- (2012) David W. Meek et al. CANCER LETTERS
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients
- (2012) S. Pesonen et al. CANCER RESEARCH
- Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs
- (2012) I. Beyer et al. CLINICAL CANCER RESEARCH
- Defining the Role of Integrin αvβ6 in Cancer
- (2012) A. Bandyopadhyay et al. CURRENT DRUG TARGETS
- Synergistic and Selective Cancer Cell Killing Mediated by the Oncolytic Adenoviral Mutant AdΔΔ and Dietary Phytochemicals in Prostate Cancer Models
- (2012) Virginie Adam et al. HUMAN GENE THERAPY
- Combined Fiber Modifications Both to Target αvβ6 and Detarget the Coxsackievirus–Adenovirus Receptor Improve Virus Toxicity Profiles In Vivo but Fail to Improve Antitumoral Efficacy Relative to Adenovirus Serotype 5
- (2012) Lynda Coughlan et al. HUMAN GENE THERAPY
- Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses
- (2012) Angela C. Bradshaw et al. JOURNAL OF CONTROLLED RELEASE
- Conserved Fiber-Penton Base Interaction Revealed by Nearly Atomic Resolution Cryo-Electron Microscopy of the Structure of Adenovirus Provides Insight into Receptor Interaction
- (2012) C. Cao et al. JOURNAL OF VIROLOGY
- Impact of Human Adenovirus Type 3 Dodecahedron on Host Cells and Its Potential Role in Viral Infection
- (2012) P. Fender et al. JOURNAL OF VIROLOGY
- A New Human DSG2-Transgenic Mouse Model for Studying the Tropism and Pathology of Human Adenoviruses
- (2012) H. Wang et al. JOURNAL OF VIROLOGY
- Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys
- (2012) H. Li et al. JOURNAL OF VIROLOGY
- Vaccination with Adenovirus Serotypes 35, 26, and 48 Elicits Higher Levels of Innate Cytokine Responses than Adenovirus Serotype 5 in Rhesus Monkeys
- (2012) Jeffrey E. Teigler et al. JOURNAL OF VIROLOGY
- Adenovirus-Mediated Sensitization to the Cytotoxic Drugs Docetaxel and Mitoxantrone Is Dependent on Regulatory Domains in the E1ACR1 Gene-Region
- (2012) Enrique Miranda et al. PLoS One
- Cysteine cathepsins: From structure, function and regulation to new frontiers
- (2011) Vito Turk et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- An oncolytic adenovirus defective in pRb-binding (dl922–947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine
- (2011) M Bhattacharyya et al. CANCER GENE THERAPY
- Epithelial Junction Opener JO-1 Improves Monoclonal Antibody Therapy of Cancer
- (2011) I. Beyer et al. CANCER RESEARCH
- The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models
- (2011) G Cherubini et al. GENE THERAPY
- Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus)
- (2011) R Alba et al. GENE THERAPY
- A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-targeting ligand improves targeted transduction
- (2011) J de Vrij et al. GENE THERAPY
- A Transductionally Retargeted Adenoviral Vector for Virotherapy of Her2/neu-Expressing Prostate Cancer
- (2011) M.K. Magnusson et al. HUMAN GENE THERAPY
- Using the Whole-Genome Sequence To Characterize and Name Human Adenoviruses
- (2011) D. Seto et al. JOURNAL OF VIROLOGY
- Unnatural Amino Acid Incorporation onto Adenoviral (Ad) Coat Proteins Facilitates Chemoselective Modification and Retargeting of Ad Type 5 Vectors
- (2011) P. S. Banerjee et al. JOURNAL OF VIROLOGY
- Adenovirus Serotype 5 Neutralizing Antibodies Target both Hexon and Fiber following Vaccination and Natural Infection
- (2011) R. R. Bradley et al. JOURNAL OF VIROLOGY
- Adenovirus Serotype 5-Specific Neutralizing Antibodies Target Multiple Hexon Hypervariable Regions
- (2011) R. R. Bradley et al. JOURNAL OF VIROLOGY
- Multimerization of Adenovirus Serotype 3 Fiber Knob Domains Is Required for Efficient Binding of Virus to Desmoglein 2 and Subsequent Opening of Epithelial Junctions
- (2011) H. Wang et al. JOURNAL OF VIROLOGY
- Magnetic Nanoparticles Enhance Adenovirus Transduction In Vitro and In Vivo
- (2011) Cédric Sapet et al. PHARMACEUTICAL RESEARCH
- Cell Entry and Trafficking of Human Adenovirus Bound to Blood Factor X Is Determined by the Fiber Serotype and Not Hexon:Heparan Sulfate Interaction
- (2011) Stéphanie Corjon et al. PLoS One
- Adenovirus type-35 vectors block human CD4+ T-cell activation via CD46 ligation
- (2011) W. C. Adams et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors
- (2010) R. Alba et al. BLOOD
- Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines
- (2010) Marie-Claude Amoureux et al. BMC CANCER
- Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma
- (2010) G Ma et al. CANCER GENE THERAPY
- Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers
- (2010) D. Oberg et al. CLINICAL CANCER RESEARCH
- Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors
- (2010) P. Nokisalmi et al. CLINICAL CANCER RESEARCH
- Clinical trials with oncolytic reovirus: Moving beyond phase I into combinations with standard therapeutics
- (2010) K.J. Harrington et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Proteoglycans in host–pathogen interactions: molecular mechanisms and therapeutic implications
- (2010) Allison H. Bartlett et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Efficacy of Oncolytic Mutants Targeting pRb and p53 Pathways Is Synergistically Enhanced When Combined with Cytotoxic Drugs in Prostate Cancer Cells and Tumor Xenografts
- (2010) Suresh Radhakrishnan et al. HUMAN GENE THERAPY
- The αvβ6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma
- (2010) E. Patsenker et al. JOURNAL OF HEPATOLOGY
- Her2-specific Multivalent Adapters Confer Designed Tropism to Adenovirus for Gene Targeting
- (2010) Birgit Dreier et al. JOURNAL OF MOLECULAR BIOLOGY
- Retargeting of Adenovirus Vectors through Genetic Fusion of a Single-Chain or Single-Domain Antibody to Capsid Protein IX
- (2010) K. L. Poulin et al. JOURNAL OF VIROLOGY
- Adenovirus-Based Vaccines: Comparison of Vectors from Three Species ofAdenoviridae
- (2010) H. Chen et al. JOURNAL OF VIROLOGY
- Structure of Adenovirus Type 21 Knob in Complex with CD46 Reveals Key Differences in Receptor Contacts among Species B Adenoviruses
- (2010) K. Cupelli et al. JOURNAL OF VIROLOGY
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
- (2010) Anniina Koski et al. MOLECULAR THERAPY
- Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
- (2010) Hongjie Wang et al. NATURE MEDICINE
- The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis
- (2010) Emma C Nilsson et al. NATURE MEDICINE
- Integrin αvβ5 is a primary receptor for adenovirus in CAR-negative cells
- (2010) Cynthia Lyle et al. Virology Journal
- PEGylated Adenoviruses: From Mice to Monkeys
- (2010) Piyanuch Wonganan et al. Viruses-Basel
- Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
- (2010) Angela C. Bradshaw et al. PLoS Pathogens
- Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens
- (2010) B. David Persson et al. PLoS Pathogens
- Polysialic acid overexpression in malignant astrocytomas
- (2009) Athanasios K. Petridis et al. ACTA NEUROCHIRURGICA
- Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
- (2009) R. C. Carlisle et al. BLOOD
- Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
- (2009) R. Alba et al. BLOOD
- Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells
- (2009) E. M. Gomes et al. CLINICAL CANCER RESEARCH
- A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses
- (2009) J J Rojas et al. GENE THERAPY
- Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob
- (2009) T Nishimoto et al. GENE THERAPY
- Replacement of Adenovirus Type 5 Fiber Shaft Heparan Sulfate Proteoglycan-Binding Domain with RGD for Improved Tumor Infectivity and Targeting
- (2009) Neus Bayo-Puxan et al. HUMAN GENE THERAPY
- Molecular mechanism and function of CD40/CD40L engagement in the immune system
- (2009) Raul Elgueta et al. IMMUNOLOGICAL REVIEWS
- Cryo-Electron Microscopy Structure of an Adenovirus-Integrin Complex Indicates Conformational Changes in both Penton Base and Integrin
- (2009) S. Lindert et al. JOURNAL OF VIROLOGY
- In Vivo Retargeting of Adenovirus Type 5 to v 6 Integrin Results in Reduced Hepatotoxicity and Improved Tumor Uptake following Systemic Delivery
- (2009) L. Coughlan et al. JOURNAL OF VIROLOGY
- Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer
- (2009) D. Liu et al. MOLECULAR CANCER THERAPEUTICS
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
- (2009) John Nemunaitis et al. MOLECULAR THERAPY
- A Strategy for Adenovirus Vector Targeting with a Secreted Single Chain Antibody
- (2009) Joel N. Glasgow et al. PLoS One
- Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells
- (2009) Miho Murakami et al. PROSTATE
- Intrabody construction and expression III: Engineering hyperstable VH domains
- (2009) Peter Wirtz et al. PROTEIN SCIENCE
- The Cell Adhesion Molecule “CAR” and Sialic Acid on Human Erythrocytes Influence Adenovirus In Vivo Biodistribution
- (2009) Elena Seiradake et al. PLoS Pathogens
- Nanoengineering Artificial Lipid Envelopes Around Adenovirus by Self-Assembly
- (2008) Ravi Singh et al. ACS Nano
- Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function
- (2008) Richard J. Stanton et al. BIOTECHNIQUES
- Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
- (2008) Simon N. Waddington et al. CELL
- Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different Affibody molecules in the fiber
- (2008) S Myhre et al. GENE THERAPY
- Adenoviruses: update on structure and function
- (2008) W. C. Russell JOURNAL OF GENERAL VIROLOGY
- Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display
- (2008) Daniel Steiner et al. JOURNAL OF MOLECULAR BIOLOGY
- Substitution of Hexon Hypervariable Region 5 of Adenovirus Serotype 5 Abrogates Blood Factor Binding and Limits Gene Transfer to Liver
- (2008) Frédéric Vigant et al. MOLECULAR THERAPY
- Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
- (2008) Irene Kuhn et al. PLoS One
- Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo
- (2008) O. Kalyuzhniy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of Cellular Heparan Sulfate Proteoglycans in Infection of Human Adenovirus Serotype 3 and 35
- (2008) Sebastian Tuve et al. PLoS Pathogens
- Polysialic acid in the plasticity of the developing and adult vertebrate nervous system
- (2007) Urs Rutishauser NATURE REVIEWS NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started